A descriptive analysis of real-world oncology biosimilar use in Japan.

Future Oncol · 2024 · PMC11486085 · PMID 38864611

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

Nonetheless, there was a significant trend in increasing use over time, with a greater proportion of patients receiving BS in each successive year of the analysis.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.